Principal Investigator
Silvia Delgado
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250069
Clinical Trial Summary
An open-label, randomized, parallel group, non-inferiority
study to investigate the pharmacokinetics,
pharmacodynamics, safety and tolerability of a new
maintenance dosing regimen of ofatumumab, followed by
extended treatment in participants with relapsing multiple
sclerosis
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Multiple Sclerosis
Contact Information
Study Contact
Gloria Rodriguez
Phone Number
+1 (305) 2438052
Email
g.rodriguez8@miami.edu